diethylstilbestrol (Also diethylstilbestrols) : Related Words Words similar in meaning to diethylstilbestrol
- stilboestrol«
- stilbestrol«
- diethylstilboestrol«
- phenol«
- diethylstilbestrol«
- de«
- teratogen«
- des.«
- oestrogen«
- synthetic«
- de daughter«
- estrogen«
- oral«
- utero«
- fda«
- nonsteroidal«
- risk«
- fosfestrol«
- postcoital contraceptive«
- pregnancy«
- prenatal de exposure«
- study«
- prenatal exposure«
- woman«
- indication«
- cell adenocarcinoma«
- adverse pregnancy outcome«
- erβ«
- pregnant woman«
- drug«
- breast engorgement«
- male«
- breast cancer«
- advanced breast cancer«
- infertility«
- erα«
- postmenopausal woman«
- rare vaginal tumor«
- postpartum lactation suppression«
- gonorrheal vaginitis«
- fda drug bulletin«
- research«
- sex sexual partner«
- estradiol«
- de exposure«
- gender«
- treatment«
- efficacy similar«
- new england journal«
- anol«
- atrophic vaginitis«
- de son«
- daughter«
- hexestrol«
- antibiotic penicillin«
- % inhibition«
- ec50 value«
- label«
- premature ovarian failure«
- prostate cancer«
- carcinogenic property«
- u.s. physician«
- menopausal symptom«
- miscarriage«
- oophorectomy«
- hypospadias«
- cryptorchidism«
- day«
- evidence«
- hormone replacement therapy«
- u.s. center«
- nci«
- girl«
- link«
- androgen«
- united state food«
- prevention«
- medical literature«
- generation«
- mother«
- placenta«
- emergency situation«
- concentration«
- animal model«
- uterus«
- vagina«
- manufacturer«
- approval«
- disease control«
- utero de exposure«
- unexposed male«
- transsexual development«
- transplacental carcinogen«
- tall adolescent girl«
- symptomatic advanced prostate cancer«
- steroidal estrogen estradiol«
- special medical exam«
- significant adverse medical complication«
- severe cervical squamous cell dysplasia«
- rn hoover«
- psychosexual effect«
- psychological anomalies«
- prenatal hormonal influence«
- positive control stimulation«
- poor sphincter control«
- patient labeling«
- occurring compound anethole«
- obesogen capable«
- noncancerous epididymal cyst«
- market de«
- male transsexual patient«
- male feminization«
- major de research scientist«
- information package insert«
- gonorrheal vaginitis indication«
- gnrh agonist leuprolide«
- female canine incontinence«
- fecho sister«
- estrogenic endocrine disrupters«
- errγ.«
- emergency postcoital contraceptive«
- embryonic male«
- dr. scott kerlin«
- de withdrawn«
- de son international research network«
- de manufacturer«
- de awareness«
- de 25mg tablet«
- carton label«
- boston federal court«
- approximate 40-fold«
- fetus«
- researcher«
- standard initial treatment«
- significant glucocorticoid activity«
- significant developmental impact«
- significant antagonism«
- regular menstrual period«
- regular combined oral contraceptive pill«
- physical intersex condition«
- nci study«
- leon golberg«
- fda final rule«
- estrogenic constituent«
- estrogenic activity«
- de research«
- cervical transformation zone«
- adult weight gain«
- individual«
- er«
- sexual orientation«
- receptor«
- undisclosed settlement amount«
- recent french study«
- longterm study«
- incompetent cervix«
- hepatic protein production«
- errβ«
- clarence hodges«
- drug administration«
- vaginal adenosis«
- sir edward charles dodds«
- recommended regimen«
- ovarian dysgenesis«
- june reinisch«
- gender identity development«
- fold preference«
- excess weight gain«
- excess height«
- environmental endocrine disruptors«
- dietary ingestion«
- dianol«
- medicine«
- beef«
- urogenital abnormality«
- unexposed woman«
- ruth l. ozeki«
- ring analogue«
- national consumer organization«
- mail card«
- errα«
- ad project«
- prevalence«
- activation«
- paroxypropione«
- generation daughter«
- daubert hearing«
- charles huggins«
- bbc series call«
- affinity«
- trimester pregnancy«
- probable link«
- lactation suppression«
- environmental estrogen«
- livestock«
- tablet«
- human«
- yuzpe regimen«
- uterine abnormality«
- sindell«
- golberg«
- female attraction«
- feed conversion«
- adulthood«
- molecular dimension«
- erα.«
- block capital letter«
- breast«
- offspring«
- united state national cancer institute«
- breast cancer mortality«
- neonatal development«
- fewer study«
- agent capable«
- uk medical research council«
- restricted condition«
- growth promotion«
- relevant dos«
- cumulative risk«
- utero exposure«
- health«
- low testosterone level«
- estrogen deficiency«
- atypical behavior«
- reinisch«
- social medium link«
- rape«
- dyson perrins laboratory«
- clinical endocrinologist«
- psychoneuroendocrinology«
- conspicuous location«
- blind clinical trial«
- metastatic prostate cancer«
- hypoestrogenism«
- errs«
- condition«
- testosterone replacement therapy«
- cervical intraepithelial neoplasia«
- pparγ«
- report«
- steroid hormone receptor«
- recurrent miscarriage«
- u national cancer institute«
- adverse health outcome«
- aace«
- gender identity issue«
- university health service«
- pharmacodynamics«
- gonadal dysgenesis«
- isotypes«
- columnar cell«
- sir robert robinson«
- prepubescent girl«
- selective estrogen receptor modulator«
- estrogenic effect«
- anethole«
- advanced prostate cancer«
- u.s. national cancer institute«
- endocrine disruptor«
- steroidal«
- orchiectomy«
- ban«
- middlesex hospital medical school«
- preterm delivery«
- pregnancy outcome«
- u study«
- mineralocorticoid receptor«
- replacement therapy«
- female transsexual«
- hormonal treatment«
- growth plate«
- intersex condition«
- lawsuit«
- wilfrid lawson«
- uterine fibroid«
- third generation«
- preeclampsia«
- drug product«
- rebuttable presumption«
- special packaging«
- pregnancy complication«
- beef industry«
- clinical effect«
- female mouse«
- finding«
- tall stature«
- pharmacokinetics«
- kinsey institute«
- synthesis«
- behavioral effect«
- effective drug«
- sexual differentiation«
- second generation«
- u.s. manufacturer«
- steroidal estrogen«
- reproductive tract«
- structural modification«
- spontaneous abortion«
- positive association«
- hypogonadism«
- cell carcinoma«
- odds ratio«
- human carcinogen«
- person«
- sexual development«
- livestock industry«
- human exposure«
- behavioral research«
- tamoxifen«
- gender dysphoria«
- cancer«
- influential study«
- menstrual period«
- lower dos«
- poultry industry«
- diverse source«
- dexamethasone«
- ectopic pregnancy«
- similar period«
- effective february«
- estrogen receptor«
- feminization«
- huge wave«
- eighth week«
- u.s. national institute«
- my year«
- initial research«
- comprehensive information«
- human male«
- abbott laboratory«
- vitro study«
- myers squibb«
- strong effect«
- limited evidence«
- estriol«
- estrone«
- theelin«
- oestrone«
- oestriol«
- oestradiol«
- mestranol«
- DES«
- 4,4'-dihydroxystilbene«
- 100mg tablet«
- 35th week«
- 14th week«
- 15th week«
- Estronol«
